Skip to Content
Merck
CN

Neonatal infectious diseases: evaluation of neonatal sepsis.

Pediatric clinics of North America (2013-03-14)
Andres Camacho-Gonzalez, Paul W Spearman, Barbara J Stoll
ABSTRACT

Neonatal sepsis remains a feared cause of morbidity and mortality in the neonatal period. Maternal, neonatal, and environmental factors are associated with risk of infection, and a combination of prevention strategies, judicious neonatal evaluation, and early initiation of therapy are required to prevent adverse outcomes. This article reviews recent trends in epidemiology and provides an update on risk factors, diagnostic methods, and management of neonatal sepsis.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Fluconazole, ≥98% (HPLC), powder
Supelco
Fluconazole, Pharmaceutical Secondary Standard; Certified Reference Material
Fluconazole, European Pharmacopoeia (EP) Reference Standard
Fluconazole for peak identification, European Pharmacopoeia (EP) Reference Standard